|
|
|
| Schedule |
|
Time |
Program |
Place |
April 24 2010
(Saturday) |
08:00-20:00 |
Registration |
Lobby, 1F, ECEC |
April 25, 2010
(Sunday) Morning |
08:20-08:40 |
Group Photo |
The Gate of ECEC, 1F |
09:00-09:35 |
Opening Ceremony |
|
09:40-11:30 |
Keynote Forum |
April 25, 2010
(Sunday) Evening |
18:30-20:30 |
Welcome Banquet and Art Performance |
|
April 25, 2010
(Sunday) Afternoon |
13:30-17:05 |
Track 1-1: Molecular Oncology on Breast Cancer(Part I) |
Room No. 7, 2F, ECEC |
13:30-17:05 |
Track 1-2: Pathology and Toxicology of Breast Cancer |
Room No. 8, 2F, ECEC |
13:30-17:05 |
Track 2-1: Gene Expression Microarrays and Recurrence Prediction |
Room No. 9, 2F, ECEC |
13: 30-15:10 |
Track 1-3: The Cancer Genomics, Epigenics and Proteomics |
Room No. 11, 2F, ECEC |
15:10-16:45 |
Track 2-2: Biomarkers in Pathway Analysis |
16:45-17:45 |
Track 3-1: Molecular Target Validations, Drug Designs and Discovery Chemistry |
13:30-15:10 |
Track 3-2: RNAi, microRNA, ncRNA and siRNA |
Room No. 12, 2F, ECEC |
15:25-17:05 |
Track 4-1: Molecular Diagnostics in Breast Cancer |
13: 30- 14:20 |
Track 3-3: Bioinformatics and Computer Aided Drug Design |
Room No. 16, 2F, ECEC |
14:10-17:05 |
Track 4-2: Diagnostic Pathology and Prognostics in Breast Cancer(Part I) |
13:30-15:10 |
Track 5-1: Adjuvant Chemotherapy and Adjuvant Targeted Therapy |
Room No. 18, 2F, ECEC |
15:25-17:05 |
Track 5-2: Tailored Radiation Therapy for Breast Cancer Stages |
April 26, 2010
(Monday) Morning |
08:30-11:15 |
Track 1-4: Epidemiology, Genetics and Prevention(Part I) |
Room No. 7, 2F, ECEC |
11:15-11:40 |
Track 5-3: Advanced Chemotherapy |
08:30-10:45 |
Track 1-5: Immunology and Immunotherapy of Breast Cancer |
Room No. 9, 2F, ECEC |
10:45-12:00 |
Track 1-6: Inflammatory Breast Cancer |
08:30-09:45 |
Track 2-3: Molecular Diagnostics with Biomarkers |
Room No. 11, 2F, ECEC |
09:50-10:10 |
Track 3-4: Biomarkers in Breast Cancer Drug Discovery |
10:25-12:05 |
Track 3-5: Targeting Nuclear and Hormone Receptor and Endocrine Therapy |
08:30-12:05 |
Track 4-3: Anatomic Breast Imaging: Mammography, Tomosynthesis, Ultrasound, MRI |
Room No. 16, 2F, ECEC |
08:30-12:05 |
Track 4-4: Functional/Molecular Breast Imaging: PEM, GSBI, Optical Breast Imaging |
Room No. 18, 2F, ECEC |
April 26, 2010
(Monday) Afternoon |
13:30-15:10 |
Track 1-1: Molecular Oncology on Breast Cancer (Part 2) |
Room No. 7, 2F, ECEC |
15:45-17:05 |
Track 4-2: Diagnostic Pathology, and Prognostics in Breast Cancer (Part II) |
13:30-14:10 |
Track 1-7: Stem/Progenitor Cells |
Room No. 9, 2F, ECEC |
14:10-12:05 |
Track 1-8: Tumor Progression, Invasion and Metastasis |
13:30-14:30 |
Track 1-9: Tumor Microenvironment and Breast Cancer |
Room No. 11, 2F, ECEC |
14:30-15:10 |
Track 3-6: Targeting Angiogenesis |
15:25-15:45 |
Track 3-7: Targeting Farnesylation |
15:45-17:05 |
Track 3-8: Targeting the MEK and the mTOR Pathway and other Novel Signaling Pathways |
13:30-15:45 |
Track 4-5: Axillary Staging and Sentinel Nodes |
Room No. 16, 2F, ECEC |
15:45-17:05 |
Track 5-4: Advanced Targeted Breast Cancer Therapy |
13:30-17:05 |
Track 4-6: Biopsy Techniques |
Room No. 18, 2F, ECEC |
April 27, 2010
(Tuesday) Morning |
08:30-10:10 |
Track 1-10: Endocrinology and Breast Cancer |
Room No. 7, 2F, ECEC |
10:25-12:05 |
Track 1-11: Translational Research in Breast Cancer |
08:30-10:10 |
Track 1-12: Growth Factors, Hormonal Factors and Receptors |
Room No. 11, 2F, ECEC |
10:25-11:40 |
Track 3-9: Targeting DNA Synthesis and Repair |
11:40-12:05 |
Track 3-10: Targeting Ubiquitin Pathway |
08:30-12:05 |
Track 1-4: Epidemiology, Genetics and Prevention(Part 2) |
Room No. 12, 2F, ECEC |
08: 30-08:55 |
Track 4-7: Circulating Markers |
Room No. 16, 2F, ECEC |
08:55-10:10 |
Track 5-5: Drug Resistance Management |
10:25-11:15 |
Track 5-6: Antibody-Based Regimens |
11:15-11:40 |
Track 5-8: Pain Management and Quality of Life |
08:30-09:20 |
Track 3-11: Inhibiting Cell Growth |
Room No. 18, 2F, ECEC |
09:20-12:05 |
Track 5-7: Tailored Surgery for Early Breast Cancer and Surgical Management of Breast Cancer Liver Metastases |
April 27, 2010
(Tuesday) Afternoon |
13:30-14:50 |
Track 1-13: Animal Models and Novel Models |
Room No. 7, 2F, ECEC |
14:50-17:05 |
Track 1-14: Oncogenes/Tumor Suppressor Genes |
13:30-17:05 |
Track 4-9: Screening and Detection |
Room No. 11, 2F, ECEC |
13:30-13:55 |
Track 3-12: Adjuvant, Neoadjuvant and Metastatic Hormonal Therapy |
Room No. 16, 2F, ECEC |
13:55-15:10 |
Track 3-13: SERMs, Aromatase Inhibitors, and SERDs |
15:25-16:15 |
Track 4-8: Imaging-Guided Staging/Re-staging of Breast Cancer: PET, MRI |
16:15-16:40 |
Track 5-9: nnovative Rational-Derived, Target-Based and Cytotoxic Therapies for Breast Cancer and Other Malignancies |
16: 40-17:05 |
Track 5-10: Ductal Carcinoma in Situ: Patient Management and Systemic Treatment |
April 28- April 29 |
|
Tour to Hangzhou and Wuzhen |
|
|
|
|